explore -WSS

explore

author：entertainment 2025-09-07 04:09:36 - browse：27

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： CommonSpirit Health keeps growing, even as it loses money

focus

WSS

An outrageous hospital charge: I paid $710 for an hour of babysitting

Alexander Hamilton and the argument for universal insurance

Intarcia’s device

Public health communication lessons from Covid

Biden announces an advanced cancer research initiative

How Vertex's cystic fibrosis drug is changing patients' lives

explore

explore

entertainment

Medicare details structure of new drug price negotiation program

Biotech stock slump in 2023: awaiting the turnaround

Cancer drug shortages should be causing more outrage

Interest rates are at a 22

How one medical school became remarkably diverse

Interest rates are at a 22

In age of alternative facts, a scholarly course on calling out crap

Biden jokes that Republicans may impeach him because inflation is starting to cool down

Malaria cases in Florida and Texas: Here’s what you need to know

CDC's new outbreak response network to include Northeastern

focus

STAT Virtual Event: Putting AI to the Test

Experts study whether long Covid risk adds up with each reinfection

Ford recalls 870K F

As the dark side of IVF slowly comes into focus, even more transparency is needed

Biden announces an advanced cancer research initiative

CDC: Cases of alpha

focus

explore

knowledge

explore